Clinical trial
Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome
NCT07136454 is registered in ClinicalTrials.gov with Oak Hill Bio Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Expanded Access/Compassionate Use of Rugonersen in Patients With Angelman Syndrome
- Lead sponsor
- Oak Hill Bio Ltd
- Phase
- Expanded access
- Overall status
- Available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.